Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026)
Incannex Healthcare (IXHL) posted Shares Outstanding (Entity) of $13.7 million for Q1 2026, up 14.27% sequentially from $12.0 million in Q4 2025, and up 1990.88% YoY from $654418.0 in Q1 2025.
Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $13.7 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1990.88% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 1990.88% YoY) and the FY2025 annual result came in at $1.1 million, up 95.29% from the prior year.
- Shares Outstanding (Entity) climbed to $13.7 million in Q1 2026 per IXHL's latest filing, from $12.0 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $13.7 million in Q1 2026 and troughed at $11667.0 in Q2 2022.
- A 5-year average of $2.9 million and a median of $588094.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 95.36% in 2022, then soared 4435.05% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $529103.0 in 2022, then advanced by 0.0% to $529104.0 in 2023, then increased by 12.05% to $592841.0 in 2024, then surged by 1919.76% to $12.0 million in 2025, then gained by 14.27% to $13.7 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $13.7 million, $12.0 million, and $11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.58 Bn | 42.62 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.27 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.12 Bn | 11.59 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.92 Bn | - | 832.44 Mn |
| 10 | Incannex Healthcare | 41.74 Mn | 41.74 Mn | - | 12.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 654,418.00 |
| Dec 31, 2024 | 587,481.00 |
| Sep 30, 2024 | 588,094.00 |
| Jun 30, 2024 | 538,811.00 |
| Mar 31, 2024 | 529,104.00 |
| Dec 31, 2023 | 529,104.00 |
| Sep 30, 2023 | 529,104.00 |
| Jun 30, 2023 | 512,823.00 |
| Mar 31, 2023 | 529,104.00 |
| Dec 31, 2022 | 513,279.00 |
| Jun 30, 2022 | 11,667.00 |
| Jun 30, 2021 | 251,372.00 |
| Jun 30, 2020 | 16,667.00 |